Primary immune thrombocytopenia (ITP) is an uncommon disease characterised by a low platelet count, which may cause the patient to have a higher risk or increased duration of bleeding. By creating this disease registry, this study will be able to build a more complete picture of ITP, including treatment practices, through collecting information about the condition from patients across several hospitals in several countries.

Australia, Colombia, Republic of Korea, Kuwait, Malaysia, Singapore, Taiwan, Thailand, Turkey, Uruguay

https://clinicaltrials.gov/ct2/show/NCT01970189?recrs=a&cond=ITP&draw=4&rank=29

Recruiting